IL-1 receptor type 2 (Immunex)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIL-1 receptor type 2 (Immunex)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsStrokeArthritis, RheumatoidOsteoporosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Inc
Active IndicationsN/A
Inactive IndicationsStrokeArthritis, RheumatoidOsteoporosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A